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As stated by Gerrard et al.[1], representing the WADA Therapeutic Use 
Exemptions (TUE) Expert Group, “TUE enables athletes with genuine ill-health to 
compete in fair, equitable competition”. In order to achieve this undisputed 
necessity, the outcome of a successful TUE application is the legalization of an 
illegal substance/method for an athlete, obtained in a manner that ensures 
confidentiality. Given the equally undeniable fact that athletes wishing to cheat, 
and those wishing to support them, will go to almost any length, an inevitable 
consequence of these two facts renders the TUE process the Achilles’ heel of anti-
doping.  
 
The misuse of the current TUE process as a ‘‘permissive’’ doping passport [2] is 
likely when any one of three fundamental principles are violated; 1) an honest 
athlete, 2) a doctor with integrity/ethics and specialist knowledge of sports and 
exercise medicine, and 3) transparent and impenetrable system of checks and 
balances of the overseeing authority (e.g., WADA). The leaks of personal medical 
records by the ‘‘Fancy Bears,’’ when interpreted in isolation, indeed do not provide 
evidence that the TUE process has been abused by elite athletes or their medical 
entourage.  Nevertheless, these leaks further undermine the credibility of sport 
when interpreted in the context of the high profile doping cases of the past 30 
years, with particular focus on the past 10 years [3], where doctors have also been 
at the center of the doping scandals and the anti-doping authorities were seemingly 
powerless to prevent this. Trust in the integrity of sport is understandably at an all 
time low. A pertinent case is the leaking of the personal medical history of cyclist 
Bradley Wiggins that included three TUEs for the powerful corticosteroid drug, 
triamcinolone, prescribed before key races in 2011, 2012, 2013 [4] -- a case of 
“permissive doping” or appropriate preventive medical treatment? 
 
Gerrard et al.[1], argue the merits of the current TUE process on the grounds that 
the standard itself withstood the rigor of scrutiny by the Court for Arbitration in Sport 
(CAS). Such scrutiny may follow once a healthy athlete will argue being 
discriminated against by the current TUE system that allows another athlete to 
use a powerful prohibited drug. 
 
There is much that can be done to help restore sport as a credible brand [3]. In 
terms of the evolution of the TUE process, new ideas such as more “structured 
transparency” may be developed, where obtained TUE’s are announced per sport 
per country – the athlete preferably anonymized with the option to be named. 
Concerns should stimulate further debate on the merits of the practice of providing 
a TUE for a powerful prohibited drug (e.g. intramuscular corticosteroid injection) in 
response to an acute medical condition, a drug that allows the athlete to compete. 
Successful athletes at major championships are not necessarily the best athletes 
but are the best-prepared athletes able to sustain hard training and avoid injury. 
Therefore, should a powerful prohibited drug be prescribed to allow an athlete to 
compete? Is this practice compatible with the spirit of sport; one of the 3 criteria [5] 
for a substance/method being included on the WADA prohibited list? What 
research is needed to develop more objective criteria to ensure those authorizing 
the TUE are confident that the prescribed medication is not enhancing the 
performance of the athlete above normal levels? 
 
In summary, our intent was not to impugn the TUE process. Quite the contrary, as 
the opinions of those who authored the article entitled “Make Sport Great Again: 
The Use and Abuse of the Therapeutic Use Exemptions Process” [2] include well 
known and respected sports physicians belonging to the Olympic movement, and 
are consistent with the spirit professed by Gerrard et al.[1]. We also encourage 
discussion and look forward to suggestions for improvement of the TUE process 
regarding specific medical conditions, not confined only to the medium of symposia 
but also through peer-reviewed scientific publications, including those that review 
the athlete’s need for a TUE medication over years, not just for the period of 
competition. 
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